Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2
Parakkal Deepak, Wooseob Kim, Michael A Paley, et al.
JCI Insight
|
February 24, 2025
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
Myra Happe, Rebecca M Lynch, Carl J Fichtenbaum, et al.
The Journal of Infectious Diseases
|
August 10, 2023
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
Nadine G Rouphael, Angela R Branche, David J Diemert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
F H van Wijk, M S Aapro, G Bolis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 26, 2024
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
Youyi Fong, Lauren Dang, Bo Zhang, et al.
Vaccine
|
February 16, 2026
The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances
Fei Heng, Craig A Magaret, Nadine G Rouphael, et al.
Nature Communications
|
January 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
Bo Zhang, Youyi Fong, Lauren Dang, et al.
Nature Medicine
|
August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Angela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Angela R Branche, Nadine G Rouphael, David J Diemert, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2
Parakkal Deepak, Wooseob Kim, Michael A Paley, et al.
JCI Insight
|
February 24, 2025
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
Myra Happe, Rebecca M Lynch, Carl J Fichtenbaum, et al.
The Journal of Infectious Diseases
|
August 10, 2023
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
Nadine G Rouphael, Angela R Branche, David J Diemert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
F H van Wijk, M S Aapro, G Bolis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 26, 2024
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
Youyi Fong, Lauren Dang, Bo Zhang, et al.
Vaccine
|
February 16, 2026
The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances
Fei Heng, Craig A Magaret, Nadine G Rouphael, et al.
Nature Communications
|
January 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
Bo Zhang, Youyi Fong, Lauren Dang, et al.
Nature Medicine
|
August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Angela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Angela R Branche, Nadine G Rouphael, David J Diemert, et al.
Page
of 10